Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

Clinical trial NCT04911777 · UNKNOWN

Trial details

NCT number

NCT04911777

Sponsor

SyneuRx International (Taiwan) Corp

Status

UNKNOWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2021-08-24

Primary completion

2021-12-01

Enrollment

90

View on ClinicalTrials.gov